These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9633469)

  • 1. [Glaucoma in the elderly].
    Le Guilloux JC
    Soins Gerontol; 1998 Apr; (12):16-8. PubMed ID: 9633469
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neuroprotection and vasoprotection in glaucoma].
    Ignat F
    Oftalmologia; 2004; 48(2):5-14. PubMed ID: 15341092
    [No Abstract]   [Full Text] [Related]  

  • 3. European Glaucoma Prevention Study.
    Quigley HA
    Ophthalmology; 2005 Sep; 112(9):1642-3; author reply 1643-5. PubMed ID: 16139678
    [No Abstract]   [Full Text] [Related]  

  • 4. Glaucoma.
    Shah R; Wormald R
    Clin Evid; 2002 Jun; (7):589-96. PubMed ID: 12230685
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of Cosopt in glaucoma treatment].
    Călugăru D; Călugăru M
    Oftalmologia; 2008; 52(4):15-25. PubMed ID: 19354158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study.
    Stewart RM; Clearkin LG
    Am J Ophthalmol; 2008 Jan; 145(1):182; author reply 182-3. PubMed ID: 18154757
    [No Abstract]   [Full Text] [Related]  

  • 7. Corneal edema after aqueous drainage device implantation.
    Wells AP; Barton K; Konstas AG
    J Glaucoma; 2007; 16(4):388-90. PubMed ID: 17571002
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.
    Janulevicienë I; Harris A; Kagemann L; Siesky B; McCranor L
    Acta Ophthalmol Scand; 2004 Dec; 82(6):730-7. PubMed ID: 15606472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diuretics, placebos, and the European glaucoma prevention study.
    Mills RP
    Am J Ophthalmol; 2007 Aug; 144(2):290-1. PubMed ID: 17659959
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the effects of 0.005% latanoprost and fixed combination dorzolamide/timolol on retrobulbar haemodynamics in previously untreated glaucoma patients.
    Martínez A; Sánchez M
    Curr Med Res Opin; 2006 Jan; 22(1):67-73. PubMed ID: 16393432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model.
    Seki M; Tanaka T; Matsuda H; Togano T; Hashimoto K; Ueda J; Fukuchi T; Abe H
    Br J Ophthalmol; 2005 Apr; 89(4):504-7. PubMed ID: 15774933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
    Tamer C; Oksüz H
    Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotony and choroidal effusion induced by topical timolol and dorzolamide in patients with previous glaucoma drainage device implantation.
    Callahan C; Ayyala RS
    Ophthalmic Surg Lasers Imaging; 2003; 34(6):467-9. PubMed ID: 14620750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraocular pressure changes in the contralateral eye after trabeculectomy with mitomycin C.
    Leung DY; Kwong YY; Yuen HK
    Br J Ophthalmol; 2006 Feb; 90(2):250. PubMed ID: 16424552
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.
    Katz LJ; Simmons ST; Craven ER
    Curr Med Res Opin; 2007 Dec; 23(12):2971-83. PubMed ID: 17949534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects.
    Konstas AG; Karabatsas CH; Lallos N; Georgiadis N; Kotsimpou A; Stewart JA; Stewart WC
    Ophthalmology; 2005 Apr; 112(4):603-8. PubMed ID: 15808251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHARMAC complicates treatment of glaucoma.
    Haddad P
    N Z Med J; 1999 Nov; 112(1099):434. PubMed ID: 10678231
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma.
    Quaranta L; Miglior S; Floriani I; Pizzolante T; Konstas AG
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4226-31. PubMed ID: 18502991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma.
    Konstas AG; Kozobolis VP; Tersis I; Leech J; Stewart WC
    Eye (Lond); 2003 Jan; 17(1):41-6. PubMed ID: 12579169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination.
    Konstas AG; Papapanos P; Tersis I; Houliara D; Stewart WC
    Ophthalmology; 2003 Jul; 110(7):1357-60. PubMed ID: 12867391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.